3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Pheochromocytoma
1
Paraganglioma
1
Osteoporosis
1
Obesity
1
Insulinoma
1
Hypertension
1
Hypercholesterolemia
1
Hyperaldosteronism
1
Growth Hormone-Secreting Pituitary Adenoma
1
Diabetes Mellitus
1
Cushing Syndrome
1
Cardiomyopathies
1
Carcinoma, Neuroendocrine
1
Adrenocortical Carcinoma
1
Adrenal incidentaloma
1
Adrenal Gland Neoplasms
1
Acromegaly
1
Interventions
fluorodopa F 18
4
Octreotide
4
Everolimus
4
Capecitabine
4
Temozolomide
3
Leucovorin
3
vatalanib
2
Trastuzumab
2
Oxaliplatin
2
Fluorouracil
2
Bortezomib
2
Bevacizumab
2
68Ga-NOTA-exendin-4
2
veliparib
1
tipifarnib
1
romidepsin
1
regorafenib
1
pentetreotide
1
pazopanib
1
pasireotide
1
motesanib diphosphate
1
cixutumumab
1
batifiban
1
Thalidomide
1
Surgical Procedures, Operative
1
Streptozocin
1
Sorafenib
1
Solutions
1
Salts
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Insulinoma
×
Observation
×
Endocrine
×
Clear all
NCT07272187
2025-12-09
EURAGIL
Herlev Hospital
Recruiting
138 enrolled